To assess the clinical relevance of RNF5 expression in AML, we analyzed levels of RNF5 mRNA and protein in peripheral blood mononuclear cells (PBMCs) from independent cohorts of AML patients. Here, RNF5 is linked to acute myeloid leukemia.